The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro
Open accessAbstract
BACKGROUND: Prostate cancer frequently metastasizes to bone. However, unlike many other tumors that produce osteolytic lesions, prostate cancer produces osteoblastic lesions through unknown mechanisms. In the current study, we explored the ability and mechanism of an osteotropic prostate cancer cell line (C4‐2B) to induce mineralization. METHODS: C4‐2B cells were grown in promineralization media. Mineral deposition was characterized using von Kossa staining, calcium retention, alizarin red staining, Raman spectroscopy, and electron microscopy. Expression of osteoblast‐related proteins was determined by RT‐PCR. The nuclear level of the bone‐specific transcription factor Cbfa1 was determined using western analysis and the effect of inhibiting Cbfa1 function, using a “decoy” Cbfa1 response element oligo, on mineralization was determined. RESULTS: The studies demonstrated that C4‐2B cells, but not its nonosteotropic parent cell line LNCaP, has an osteoblastlike phenotype including production of alkaline phosphatase, osteocalcin, osteonectin, bone sialoprotein, osteoprotegerin (OPG), and OPG ligand. Most importantly, the C4‐2B cells produced hydroxyapatite mineral in vitro. Furthermore, C4‐2B cells expressed high nuclear levels of the bone‐specific transcription factor Cbfa1, compared to LNCaP cells, which accounts for their ability to produce bone‐specific proteins. Inhibition of Cbfa1, using decoy DNA Cbfa1 response elements, abrogated the ability of C4‐2B to produce mineral. Finally, we determined that C4‐2B cells express bone morphogenic protein‐7, a known inducer of Cbfa1 expression. CONCLUSIONS: These data demonstrate a novel mechanism through which prostate cancer cells may directly contribute to the osteoblastic component that characterize their skeletal metastatic lesions. Prostate 47:212–221, 2001. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Cited by
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Xu, K., Wu, Z. J., Groner, A. C., He, H. H., Cai, C., Lis, R. T., Wu, X., Stack, E. C., Loda, M., Liu, T., et al. (2012) · Science · doi:10.1126/science.1227604 · Cited by 875
Zhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452
Self-citationMOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
CHUNG, L. W. K., BASEMAN, A., ASSIKIS, V., & ZHAU, H. E. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 361
Prostate Cancer Cells Promote Osteoblastic Bone Metastases through Wnts
Hall, C. L., Bafico, A., Dai, J., Aaronson, S. A., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1317 · Cited by 303
Self-citationProstate cancer bone metastases promote both osteolytic and osteoblastic activity
Keller, E. T., & Brown, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10662 · Cited by 298
Self-citationKaden, J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.015 · Cited by 285
RANK ligand and osteoprotegerin in myeloma bone disease.
Sezer, O., Heider, U., Zavrski, I., Kühne, C. A., & Hofbauer, L. C. (2003) · Blood · doi:10.1182/blood-2002-09-2684 · Cited by 258
Differential Gene Expression in Ovarian Carcinoma
Hibbs, K., Skubitz, K. M., Pambuccian, S. E., Casey, R. C., Burleson, K. M., Oegema, T. R., Thiele, J. J., Grindle, S. M., Bliss, R. L., & Skubitz, A. P. N. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63306-8 · Cited by 256
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity
Kitagawa, Y., Dai, J., Zhang, J., Keller, J. M., Nor, J., Yao, Z., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1809 · Cited by 101
Self-citation
Metadata
- Authors
- Lin, D., Tarnowski, C. P., Zhang, J., Dai, J., Rohn, E., Patel, A. H., Morris, M. D., & Keller, E. T.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2001-05
- Volume
- 47
- Issue
- 3
- Pages
- 212-221
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2033890749
- Cited by
- 163
- References
- 2
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.